NYSE
$90.24▲ 1.27%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $51.96BShares out 5.800M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
26- 10.8After-hours26.10.09 06:244Ownership#●●●#●●●
Edwards Lifesciences Corp
Daniel J. Lippis, an executive at Edwards Lifesciences Corp, filed a statement of changes in beneficial ownership of securities on October 8, 2026. This filing serves as a standard disclosure regarding the change in the insider's stock holdings.…more
$90.24+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.14After-hours26.09.15 07:044Ownership
Edwards Lifesciences Corp
Wayne Markowitz, an executive at Edwards Lifesciences Corp, reported a change in beneficial ownership of securities as of September 11, 2026. This filing serves as a standard disclosure of insider equity transactions via Form 4.…more
$90.24+1.27%vs prev closeView filingShare - 9.14After-hours26.09.15 07:044Ownership
Edwards Lifesciences Corp
Edwards Lifesciences Corp executive Andrew M. Dahl filed a Form 4 on September 14, 2026, reporting changes in beneficial ownership of securities as of September 13, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
$90.24+1.27%vs prev closeView filingShare
25 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.16Regular26.10.17 00:13Bullish#●●●#●●●
Edwards Lifesciences Recalls High-Risk Heart Device Following Patient Death…more
Edwards Lifesciences has issued a high-risk recall for its heart valve delivery systems due to balloon bursting issues that led to a patient death. This safety concern poses potential risks to the company's product reputation and financial performance.…more
$90.24+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.16Overnight26.10.16 16:50
●●●●●●●● ●●●●● ●●●●●●
Edwards Lifesciences has advised customers to remove specific lots of its Commander M delivery systems for SAPIEN M3 due to potential high-risk issues. The FDA has flagged the situation, leading to a formal medical device recall.…more
$90.24+1.27%vs prev closeShareBenzinga - 10.2Regular26.10.02 23:46
●●●●●●●● ●●●●● ●●●●●●
Edwards Lifesciences has secured FDA clearance for its AUTUS size-adjustable heart valve designed for pediatric patients. This innovative device can expand as a child grows, potentially reducing the need for multiple open-heart surgeries.…more
$90.24+1.27%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report